Le Lézard
Classified in: Health
Subject: RCL

Advisory - Unauthorized sexual enhancement products seized from Eden Wholesale and Retail Adult Toys in Scarborough, ON, may pose serious health risks


OTTAWA, July 06, 2021 /CNW/ - Health Canada is advising Canadians that the following products may pose serious health risks. For more information, including what Canadians should do, visit the online safety alert.

Health Canada maintains a list of unauthorized health products that may pose serious health risks so that Canadians can easily identify those they may have purchased and take appropriate action. Canadians are encouraged to check back regularly for updates.

Unauthorized health products

Product &
Promoted Use

Hazard Identified

Company

Action Taken

7K

Sexual enhancement

 

Labelled to contain yohimbe

Eden Wholesale and Retail Adult Toys

1843 Lawrence Ave E., Scarborough, ON

Seized from the retail location

Rhino 7 Platinum 5000

Sexual enhancement

Product with similar packaging (previously seized) was tested and found to contain sildenafil and yohimbine

Eden Wholesale and Retail Adult Toys

1843 Lawrence Ave E., Scarborough, ON

Seized from the retail location

Spanish Fly 20,000

Sexual enhancement

Product with similar packaging (previously seized) was tested and found to contain tadalafil

Eden Wholesale and Retail Adult Toys

1843 Lawrence Ave E., Scarborough, ON

Seized from the retail location

Stiff Rox

Sexual enhancement

Product with similar packaging (previously seized) was tested and found to contain sildenafil and tadalafil

Eden Wholesale and Retail Adult Toys

1843 Lawrence Ave E., Scarborough, ON

Seized from the retail location

Triple Green

Sexual enhancement

Labelled to contain yohimbe

Eden Wholesale and Retail Adult Toys

1843 Lawrence Ave E., Scarborough, ON

Seized from the retail location

White Panther

Sexual enhancement

Labelled to contain yohimbe

Eden Wholesale and Retail Adult Toys

1843 Lawrence Ave E., Scarborough, ON

Seized from the retail location

Images

For photos of these products, please visit the online safety alert.

Stay connected with Health Canada and receive the latest advisories and product recalls.

Également disponible en français

SOURCE Health Canada


These press releases may also interest you

at 06:03
The IAMStm brand, proudly part of the Mars family of brands, announced today the launch of the IAMStm Puppy Hub and Kitten Hub, two online tools featuring expert knowledge and advice for new and soon-to-be pet parents. Each Hub will bring...

at 06:00
Today, TELUS Health announced a collaboration with Nova Scotia Health (NSH) to enable residents of Nova Scotia to access their primary care information through the YourHealthNS app. This health data interoperability initiative marks the first...

at 05:30
The global Digital Healthcare Market, valued at $220.10 billion in 2024, is on a trajectory of rapid expansion, with projections indicating it will soar to $836.10 billion by 2031, growing at a compound annual growth rate (CAGR) of 21% from 2024 to...

at 05:09
Medical imaging IT and cybersecurity company Sectra (STO: SECT B) is publishing its Annual Report and Sustainability Report for the 2023/2024 fiscal year today. This report also includes the Corporate Governance Report for the same period. The...

at 03:20
Calliditas Therapeutics AB (STO: CALTX) ("Calliditas") today announces that its partner Viatris Pharmaceutical Japan G.K. ("Viatris") has initiated a phase III clinical trial in Japan with Nefecon, named VR-205 in the Japanese market, in Japanese...

at 03:00
Global biotechnology leader CSL Behring today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the...



News published on and distributed by: